1246471-38-4 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 3-Cyclopropylpyrazole-4-carboxylate is used as a key intermediate in the synthesis of new drug molecules, leveraging its unique structural features to improve drug efficacy and selectivity. Its cyclopropyl substitution can modulate the pharmacokinetic and pharmacodynamic properties of drug candidates, potentially leading to the development of more effective therapeutic agents.
Used in Agricultural Industry:
In the agricultural sector, Ethyl 3-Cyclopropylpyrazole-4-carboxylate serves as a crucial building block for the creation of innovative agrochemicals. Its unique properties can be harnessed to design pesticides or herbicides with enhanced activity and selectivity, contributing to more effective and sustainable crop protection strategies.
Overall, Ethyl 3-Cyclopropylpyrazole-4-carboxylate is a versatile chemical intermediate with significant potential in both pharmaceutical and agricultural applications, driving the development of novel and improved products in these fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1246471-38-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,6,4,7 and 1 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1246471-38:
(9*1)+(8*2)+(7*4)+(6*6)+(5*4)+(4*7)+(3*1)+(2*3)+(1*8)=154
154 % 10 = 4
So 1246471-38-4 is a valid CAS Registry Number.
1246471-38-4Relevant academic research and scientific papers
PYRROLIDINE DERIVATIVES AS INHIBITOR OF FIBROBLAST ACTIVATION PROTEIN (FAP) AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
-
Paragraph 0545; 0549-0551, (2020/11/24)
The FAP inhibitor is represented by the following formula X. The present invention relates to a pyrrolidine derivative or a pharmaceutically acceptable salt thereof. Chem. X.
LXR MODULATORS
-
Page/Page column 69, (2014/10/04)
The present invention provides compounds of Formula I and Formula II: or pharmaceutically acceptable salts or solvates thereof, as modulators of liver X receptors (LXRs), and compositions comprising any of such novel compounds and methods of use thereof. These compounds are useful as medicaments for treatment and/or prophylaxis for diseases or conditions related to activity of LXRs.
